COMMUNIQUÉS West-GlobeNewswire

-
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
28/05/2024 -
Longeveron® to Attend BIO International Convention 2024
28/05/2024 -
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
28/05/2024 -
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
28/05/2024 -
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
28/05/2024 -
Spectral AI to Participate in Benzinga’s “AI Unleashed: Exploring the Possibilities” Virtual Event
28/05/2024 -
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
28/05/2024 -
Avalyn to Participate in Jefferies Global Healthcare Conference
28/05/2024 -
HiberCell Announces First Patient Dosed in Phase 1b Clinical Trial, Evaluating HC-7366 in Combination with Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia (AML)
28/05/2024 -
PetMed Express, Inc. Appoints Carla Dodds as New Chief Marketing Officer
28/05/2024 -
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)
28/05/2024 -
Aummune’s Poster at ASCO 2024 to Highlight Ongoing Phase 1 Trial for AM003
28/05/2024 -
DLH Announces Participation in Upcoming Events
28/05/2024 -
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
28/05/2024 -
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)
28/05/2024 -
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
28/05/2024 -
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference
28/05/2024 -
REPEAT – Large Protests This Week Across Ontario in Response to Ford Government’s Health Care Privatization & Closures of Local Hospitals
28/05/2024 -
Nanox Announces First Quarter of 2024 Financial Results and Provides Business Update
28/05/2024
Pages